Literature DB >> 16234509

Comorbid disease and cancer: the need for more relevant conceptual models in health services research.

Jane M Geraci1, Carmen P Escalante, Jean L Freeman, James S Goodwin.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16234509      PMCID： PMC1853249          DOI： 10.1200/JCO.2004.00.9753

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  49 in total

Review 1.  Managing comorbidities in patients at the end of life.

Authors:  James Stevenson; Amy P Abernethy; Cathy Miller; David C Currow
Journal:  BMJ       Date:  2004-10-16

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Patient factors associated with breast cancer screening among older women.

Authors:  S L Marwill; K M Freund; P P Barry
Journal:  J Am Geriatr Soc       Date:  1996-10       Impact factor: 5.562

4.  Cancer treatment protocols. Who gets chosen?

Authors:  J S Goodwin; W C Hunt; C G Humble; C R Key; J M Samet
Journal:  Arch Intern Med       Date:  1988-10

5.  The effect of comorbidity on 3-year survival of women with primary breast cancer.

Authors:  W A Satariano; D R Ragland
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

6.  Determinants of cancer therapy in elderly patients.

Authors:  J S Goodwin; W C Hunt; J M Samet
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

7.  Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis.

Authors:  Daniel H Solomon; Elizabeth W Karlson; Gary C Curhan
Journal:  Arthritis Rheum       Date:  2004-06-15

8.  Dementia assessment in primary care: results from a study in three managed care systems.

Authors:  Linda Boise; Margaret B Neal; Jeffrey Kaye
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-06       Impact factor: 6.053

9.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

10.  A population-based study of functional status and social support networks of elderly patients newly diagnosed with cancer.

Authors:  J S Goodwin; W C Hunt; J M Samet
Journal:  Arch Intern Med       Date:  1991-02
View more
  28 in total

1.  Different effects of multiple health status indicators on breast and colorectal cancer screening in a nationally representative US sample.

Authors:  Anjali D Deshpande; Amy McQueen; Elliot J Coups
Journal:  Cancer Epidemiol       Date:  2011-11-11       Impact factor: 2.984

2.  Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.

Authors:  Matteo G Della Porta; Ilaria Ambaglio; Marta Ubezio; Erica Travaglino; Cristiana Pascutto; Luca Malcovati
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

3.  Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Mario Cazzola
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

4.  Chronic condition clusters and functional impairment in older cancer survivors: a population-based study.

Authors:  Kelly M Kenzik; Erin E Kent; Michelle Y Martin; Smita Bhatia; Maria Pisu
Journal:  J Cancer Surviv       Date:  2016-05-27       Impact factor: 4.442

5.  Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.

Authors:  Kristen L Fessele; Matthew J Hayat; Robert L Atkins
Journal:  Oncol Nurs Forum       Date:  2017-09-01       Impact factor: 2.172

6.  Associations between physical activity and comorbidities in Korean cancer survivors.

Authors:  Dong-Woo Kang; Eun-Young Lee; Ki Yong An; Jihee Min; Justin Y Jeon; Kerry S Courneya
Journal:  J Cancer Surviv       Date:  2018-03-01       Impact factor: 4.442

7.  Geriatric assessment-identified deficits in older cancer patients with normal performance status.

Authors:  Trevor A Jolly; Allison M Deal; Kirsten A Nyrop; Grant R Williams; Mackenzi Pergolotti; William A Wood; Shani M Alston; Brittaney-Belle E Gordon; Samara A Dixon; Susan G Moore; W Chris Taylor; Michael Messino; Hyman B Muss
Journal:  Oncologist       Date:  2015-03-12

8.  Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.

Authors:  Jennifer H Jordan; Soe Soe Thwin; Timothy L Lash; Diana S M Buist; Terry S Field; Reina Haque; Pamala A Pawloski; Hans V Petersen; Marianne N Prout; Virginia P Quinn; Marianne Ulcickas Yood; Rebecca A Silliman; Ann M Geiger
Journal:  Breast Cancer Res Treat       Date:  2014-06-18       Impact factor: 4.872

9.  Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome.

Authors:  Matteo Giovanni Della Porta; Luca Malcovati
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

10.  Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.

Authors:  S Yousuf Zafar; Amy P Abernethy; David H Abbott; Steven C Grambow; Jennifer E Marcello; James E Herndon; Krista L Rowe; Jane T Kolimaga; Leah L Zullig; Meenal B Patwardhan; Dawn T Provenzale
Journal:  BMC Cancer       Date:  2008-11-25       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.